Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Hims & Hers Health Inc (NYSE: HIMS) was $37.04 for the day, down -0.99% from the previous closing price of $37.41. In other words, the price has decreased by -$0.99 from its previous closing price. On the day, 17.47 million shares were traded. HIMS stock price reached its highest trading level at $38.69 during the session, while it also had its lowest trading level at $35.77.
Ratios:
Our analysis of HIMS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 27.41 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.49. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Morgan Stanley on February 18, 2025, Downgraded its rating to Equal-Weight and sets its target price to $60 from $42 previously.
On January 10, 2025, Citigroup Downgraded its rating to Sell which previously was Neutral and also upped its target price recommendation from $24 to $25.
On January 07, 2025, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on January 07, 2025, with a $35 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 21 ’25 when Okupe Oluyemi sold 23,118 shares for $32.41 per share. The transaction valued at 749,176 led to the insider holds 129,248 shares of the business.
Oluyemi Okupe bought 69,442 shares of HIMS for $2,413,110 on Mar 21 ’25. On Mar 18 ’25, another insider, Carroll Patrick Harrison, who serves as the Chief Medical Officer of the company, sold 23,287 shares for $34.31 each. As a result, the insider received 798,977 and left with 209,661 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HIMS now has a Market Capitalization of 8311220224 and an Enterprise Value of 7940106752. As of this moment, Hims’s Price-to-Earnings (P/E) ratio for their current fiscal year is 69.26, and their Forward P/E ratio for the next fiscal year is 43.07. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.23. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.57 while its Price-to-Book (P/B) ratio in mrq is 17.16. Its current Enterprise Value per Revenue stands at 5.378 whereas that against EBITDA is 95.567.
Stock Price History:
The Beta on a monthly basis for HIMS is 1.56, which has changed by 1.3532403 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, HIMS has reached a high of $72.98, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is -4.89%, while the 200-Day Moving Average is calculated to be 42.61%.
Shares Statistics:
HIMS traded an average of 21.88M shares per day over the past three months and 21889680 shares per day over the past ten days. A total of 212.46M shares are outstanding, with a floating share count of 181.97M. Insiders hold about 18.09% of the company’s shares, while institutions hold 73.60% stake in the company. Shares short for HIMS as of 1740700800 were 51844511 with a Short Ratio of 2.37, compared to 1738281600 on 58208349. Therefore, it implies a Short% of Shares Outstanding of 51844511 and a Short% of Float of 26.520001999999998.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
